Aemetis’s dairy credit reset brings interest coverage closer
Key Takeaways
- The federal dairy credit reset raised recurring earnings. Of the $24.7M in 45Z revenue, roughly $11.0M related to first-half production. Without the catch-up, adjusted EBITDA was about $13.8M, up from $9.7M in Q2 but still below $15.8M of financing expense.
- The preferred amendment buys four months and lowers the fallback rate. The $117.3M redemption moved to December 31. Senior demand debt rose to $280.6M and Keyes again needed covenant waivers.
- Keyes will likely see most of its vapor recompression benefit in the second half of 2027. Two new dairy digesters began operating in October, while higher corn costs cut into the benefit of better ethanol prices in Q3.
- Rating: Maintaining Hold. At the $1.73 reaction close, cheaper refinancing could unlock substantial upside, but delays in commissioning or credit receipts leave common holders exposed to another round of borrowing and dilution.
Results vs. Consensus
| Q3 FY2026 metric | Actual | Consensus | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Revenue | $88.153M | $69.7M | Beat | +26.5% |
| GAAP diluted EPS | $(0.02) | $(0.20) | Beat | +$0.18 |
| GAAP basic EPS | $0.07 | n/a | n/a | n/a |
| Gross margin | 33.4% | n/a | n/a | n/a |
| Operating income | $20.852M | n/a | n/a | n/a |
| Adjusted EBITDA | $24.789M | n/a | n/a | n/a |
Published sales estimates ranged from $69.7M to $75.2M. Aemetis cleared even the high end after removing the dairy catch-up, at roughly $77.2M. The better test of demand was the $63.5M in sales excluding all 45Z, up 7.2% year over year. California sales on that basis grew 23.1%, offset in part by lower Indian tender volumes.
Year-over-year comparison
| $000s except margins and EPS | Q3 FY2026 | Q3 FY2025 | Change |
|---|---|---|---|
| Revenue | 88,153 | 59,190 | +48.9% |
| Cost of goods sold | 58,680 | 59,248 | −1.0% |
| Gross profit (loss) | 29,473 | (58) | +29,531 |
| Gross margin | 33.4% | (0.1)% | +3,353 bps |
| SG&A | 8,621 | 8,450 | +2.0% |
| Operating income (loss) | 20,852 | (8,508) | +29,360 |
| Operating margin | 23.7% | (14.4)% | +3,803 bps |
| Total interest expense | 15,764 | 14,984 | +5.2% |
| Net income (loss) | 5,211 | (23,747) | +28,958 |
| GAAP EPS, basic | $0.07 | $(0.37) | +$0.44 |
| GAAP EPS, diluted | $(0.02) | $(0.37) | +$0.35 |
| Adjusted EBITDA | 24,789 | (5,038) | +29,827 |
Sequential comparison
| $000s except margins and EPS | Q3 FY2026 | Q2 FY2026 | Change |
|---|---|---|---|
| Revenue | 88,153 | 62,700 | +40.6% |
| Gross profit | 29,473 | 13,515 | +15,958 |
| Gross margin | 33.4% | 21.6% | +1,188 bps |
| Operating income | 20,852 | 5,773 | +15,079 |
| Total interest expense | 15,764 | 15,174 | +3.9% |
| Net income (loss) | 5,211 | (9,367) | +14,578 |
| GAAP EPS, diluted | $(0.02) | $(0.13) | +$0.11 |
| Adjusted EBITDA | 24,789 | 9,666 | +15,123 |
| Cash and cash equivalents | 3,359 | 973 | +2,386 |
Quality of the beat
Without the first-half true-up, gross margin was about 23.9% and net income would have been a loss of about $5.8M, holding other lines fixed. Gross profit excluding all 45Z was $4.8M, close to $4.9M in Q2. The stronger underlying quarter came primarily from a higher credit on current dairy output, while the non-45Z businesses preserved the gross profit improvement established in Q2.
The basic and diluted EPS split matters for common holders. Assuming conversion of the Biogas preferred into subsidiary common units removes $6.945M from the parent’s diluted earnings numerator after the accretion add-back. That leaves a $1.734M diluted loss on the same 72.5M weighted shares. The EPS treatment illustrates how much of the profitable dairy business can accrue to the preferred holder. Separately, ATM issuance diluted the parent’s common shareholders.
Segment Performance
| Q3 FY2026, $000s | Revenue | Revenue YoY | Gross profit | Gross margin | Segment net income (loss) |
|---|---|---|---|---|---|
| California Ethanol | 53,804 | +32.1% | 7,444 | 13.8% | (3,826) |
| California Dairy RNG | 25,923 | +548.7% | 20,639 | 79.6% | 16,782 |
| India Biodiesel | 8,426 | −41.8% | 1,390 | 16.5% | 671 |
| All Other | 0 | n/a | 0 | n/a | (8,416) |
| Total | 88,153 | +48.9% | 29,473 | 33.4% | 5,211 |
Key operating metrics
| Operating metric | Q3 FY2026 | Q2 FY2026 | Q3 FY2025 |
|---|---|---|---|
| Ethanol sold, million gallons | 15.6 | 15.5 | 14.7 |
| Ethanol realized, $/gallon | $2.34 | $2.19 | $2.13 |
| Corn cost, $/bushel | $6.29 | $6.07 | $5.95 |
| Dairy RNG sold, MMBtu | 158,200 | 146,900 | 114,000 |
| LCFS realized, $/credit | $73 | $66 | $54 |
| India biodiesel sold, thousand metric tons | 6.6 | 1.4 | 12.5 |
California Ethanol
Keyes sold more ethanol at higher prices and earned more on wet distillers grains. Excluding $4.635M of 45Z, segment revenue rose 20.7% to $49.2M from a year earlier. Higher corn costs absorbed part of the improvement. Ex-45Z gross profit rose to $2.8M from roughly $2.4M in Q2, even as reported segment gross profit declined on lower recognized credits. At this quarter’s 5.4M bushels of grind, another $0.10 a bushel would cost roughly $0.54M before any change in product prices.
Assessment. Strong throughput supports the standing operating thesis. Gross profit outside 45Z improved modestly as higher feedstock costs ate into better product pricing. At $9.4M of segment interest and debt amortization versus $6.7M of segment EBITDA, the energy retrofit still has to close a real funding gap.
California Dairy Renewable Natural Gas
RNG sold grew 39%, while RIN and LCFS sales reached $3.4M and $2.0M. Customer revenue excluding 45Z rose 47% to $5.9M. The realized natural-gas price fell from $3.45 to $3.16 per MMBtu, so the growth came from volume and the attached environmental attributes. Quarterly gross profit after stripping out the first-half true-up was about $9.6M, more than double Q2’s $4.0M.
Assessment. The higher dairy credit establishes a materially better margin on existing volumes. Seven provisional California pathways already improve credit generation. For the next digesters, the amount common holders can capture still depends on capital terms and how quickly provisional pathways translate into realized sales.
India Biodiesel
Biodiesel sales rebounded to $7.34M as deliveries resumed under the tender awarded in late July. The $8.43M segment total includes $1.09M of other sales. Volume recovered from 1.4K tonnes in Q2 to 6.6K but was still roughly half the 12.5K a year ago. Segment gross profit improved year over year on cheaper feedstock despite the lower volume.
Assessment. The tender delivered a partial recovery. The company has yet to quantify private-channel sales separately, and European shipments need approvals and a workable delivered spread. We carry the rebound into Q4 and retain the prior view that any IPO lies in 2027 at the earliest. We assign no standalone value to an IPO or to Riverbank SAF in the base case.
Key Topics & Management Commentary
Overall management tone. Management sounded more assured about benefits it could now quantify, especially the dairy credit. It also acknowledged a slower Keyes commissioning schedule and described financing discussions in tentative terms, much as it did in August.
1. A lower preferred rate buys time for Keyes and Biogas
The old September 1 conversion did not occur. The thirteenth amendment was executed on October 10 with an August 31 effective date. It moves redemption to December 31. The $117.3M aggregate obligation comprises $95.8M of redemption consideration plus a $21.5M closing fee, of which $2M is incremental under the amendment. If unredeemed, a credit agreement effective January 1, 2027 and due January 1, 2028 would carry the greater of prime plus five points or 12%, versus the prior 16% floor. The preferred is secured on the Biogas assets and carried separately from debt at $123.6M. The proposed facility allows interest capitalization while no default is continuing and sweeps 100% of defined quarterly free cash flow of Biogas and its subsidiaries toward repayment. The definition includes certain grants, financing and tax credit proceeds after cash debt service and a $1M working capital reserve. The amendment also waived missed per-digester and aggregate operating cash flow tests.
The Keyes waiver covered the same debt-to-plant-value and capex covenants as in June. Meanwhile current debt rose from $354.2M to $376.9M and Third Eye’s demand balance rose from $269.6M to $280.6M. Management still describes the long-term Keyes financing as being in preparation. Aemetis continues to report substantial doubt about its ability to continue as a going concern over the next twelve months.
Assessment. The preferred change lowers the fallback carrying cost and gives the parties through year-end to find a different outcome. Repeat waivers and the growing demand balance keep any reduction in parent financing costs outside our base case.
2. The dairy credit lands ahead of the remaining ethanol gains
The September 8 model reset increased management’s gross dairy credit estimate to about $62 per MMBtu, up from $15.20 in the July sale and below the prior $75 scenario. The quarter recognized about $9.1M on current-period dairy output and $4.6M on ethanol, in addition to the dairy true-up. Aemetis can now document regenerative corn practices under the revised model. It has yet to book an incremental corn-rate uplift or a CO₂ reuse credit, and the dairy look-back covered 2026 first-half dispensing.
Assessment. We include the dairy reset in recurring estimates and leave both the incremental ethanol items and a potential ethanol look-back outside the base. Adjusted EBITDA covered 1.57× total interest as reported and 0.87× without the true-up, up from 0.64× in Q2. The recurring improvement partly meets the prior DOE upgrade test. It still takes additional margin or lower interest to cover the financing cost before capex.
3. Two credit sales improve cash flow while debt keeps growing
Aemetis collected $17.6M in July and $22.4M in September from credit sales. Subtracting first-half cash flow from the nine-month statement gives Q3 operating cash flow of $22.0M and capex of $20.2M, leaving $1.7M before financing and foreign exchange. Cash interest paid was only $2.8M in Q3 against $15.8M of total interest expense, which also includes noncash preferred accretion and debt fees. Q3 payments on preferred financing were $7.9M. Unrestricted cash ended at $3.4M.
The new filing describes deciding with the senior lender how to allocate proceeds among repayments and operating needs. It gives no sale-level split. Total debt increased $19.6M sequentially to $435.4M, even after cash receipts improved and the quarter’s ATM sales slowed to 0.9M shares for $1.8M.
Assessment. A second credit sale lowers execution risk. Cash flow supported this quarter’s investment partly because Aemetis paid little of its accrued financing cost in cash. The repeatable test is whether current-period credits and operating margin can pay those costs without growing the senior balance.
4. The Keyes retrofit shifts from year-end commissioning into 2027
The vapor recompression project uses electricity in place of much of the plant’s fossil gas. Foundations are in place and major equipment has arrived, but electrical equipment and commissioning are still on the critical path. Management reiterated that the system would reduce fossil gas use by about 80%. The prior call split the $32M annual benefit into about $8M from gas and $24M from credits. Management now sees the larger income statement effect in the second half of 2027, with certification and monetization timing important for cash.
Assessment. We expect roughly half a year of gas savings and less than half of the estimated full-year credit uplift. This puts more weight on the funded gas-saving project while leaving room for a lag between startup, verification and receipt of the credit cash.
5. The two digesters start just after quarter-end
The two digesters expected by the end of Q3 started in October, taking the network to 14 digesters serving 17 dairies. The company expects about 600,000 MMBtu of annual production from that network. A simple annualization of summer-quarter sales would overstate our run-rate given winter seasonality. Management sees six more California pathways nearing approval with the customary look-back. It also targets November fleet deliveries from its first RNG station.
“These LCFS pathway approvals substantially expand the LCFS credit generation per MMBtu of RNG produced.”
— Eric McAfee, Chairman and CEO
Assessment. We carry the 600,000 MMBtu production case and realized LCFS prices in the low $70s. Approvals and the fueling station can raise realized value per unit, while the next wave of digesters depends on financing. That keeps expansion optionality outside the base until funding closes.
6. Corn oil is the nearer Keyes margin opportunity
Two separation units are installed and the third is targeted for December, later than the fall timetable discussed last quarter. The extra oil can be sold into renewable diesel, biodiesel and SAF feedstock markets. Its value depends on how much is recovered and what those buyers pay.
“Combined, the units are expected to approximately double corn oil production compared to our first quarter production rate.”
— Eric McAfee, Chairman and CEO
Assessment. We estimate $2.7M of FY2027 incremental EBITDA from additional corn oil sales versus the Q3 run-rate. That estimate includes commissioning and margin risk and carries no separate price increase. Our $3.5M annual sales increment assumes a measured increase against a Q3 run rate that already includes output from two units. It amounts to roughly one-quarter of the annualized other-sales bucket, which includes products beyond corn oil.
Guidance & Outlook
Aemetis provided operating milestones in place of consolidated sales and earnings guidance. Those targets imply little Q4 help from the third oil separator and essentially no Q4 benefit from vapor recompression. Q4 therefore depends on the normal-rate dairy credits, the seasonal volume tradeoff from the new digesters and further India deliveries.
| Milestone | Q2 expectation | Q3 update |
|---|---|---|
| Two dairy digesters | Commission in Q3 | Operating in October |
| Third corn oil unit | Fall 2026 | December target |
| Vapor recompression | End-2026 commissioning target | Construction around March if schedule holds. Financial benefit weighted to H2 2027. |
| Six additional LCFS pathways | Approval and look-back pending | Still in process |
| India volumes | Deliver under $17M allocation | Deliveries under way. Management expects export approvals in Q4. |
| Keyes financing | Long-term financing in preparation | Long-term financing in preparation |
We estimate Q4 revenue of about $78M and adjusted EBITDA of about $14M. The $11M catch-up rolls off. Further India deliveries and higher installed dairy capacity offset some winter pressure on RNG yields. Without a step-down in interest, we expect another quarterly net loss.
Analyst Q&A Highlights
How fast vapor recompression can contribute
Asked which year would capture the benefit, the plant team put construction completion in the first half of 2027, with March a tentative target.
Q: “Just going to the MVR, it looks like all the equipment is in place. You know, the work is underway. The benefits from this should we expect that to come through in 2027 financials or 2028 financials?”
— Amit Dayal, H.C. Wainwright
A: “We are making good progress and expect hopefully, by March, we will be completed with construction. Commissioning will take some time. It is a new system. And so I would say, you know, in terms of financial impact, you are probably gonna see it more in the second half of next year than you will in the first half of next year because we will be completing construction sort of commissioning the system, getting it up and running, and then and then we will start to see that, that impact. The natural gas impact will happen pretty quickly, though, because once we switch over to the MVR system, we will not be drawing down the 37 hundred MMBtus that we are currently using daily.”
— Andy Foster, President of Aemetis Advanced Fuels
Assessment. The gas benefit can start during commissioning. Because the credit uplift follows verification, our 2027 model gives more weight to gas savings relative to their eventual share of the benefit.
European biodiesel approvals and practical capacity
The question probed approval timing and possible export limits. Management cited a Q4 target for approvals and said shipping logistics would determine how much could actually move. Its expected commercial route is through traders.
Q: “This India biodiesel to Europe sounds very interesting. You know, how long could this approval process take, and would you be capped at what portion of that capacity can be exported?”
— Amit Dayal, H.C. Wainwright
A: “The approvals are largely in process. We do expect them to be completed in the fourth quarter of this year. And we have not a cap on export. […] We have just practical execution of inbound shipments of feedstock and outbound shipments of biodiesel that will be larger constraints on the on the amount we ship.”
— Eric McAfee, Chairman and CEO
Assessment. Trader access could smooth the tender cycle, but the call provided no shipment commitment or evidence that delivered margins cover the incremental logistics costs. The estimate relies on Indian demand.
Funding the next group of digesters
The analyst pressed for a pace of completions in 2027. Management offered no funded count.
Q: “Just on the dairy RNG business, as you look out into next year and the pipeline of the farms that you guys have to bring on, what is the what kind of pace would you expect for next year?”
— Derrick Whitfield, Texas Capital
A: “We have financing in process right now. I think that news is something we will be reporting here over the next couple months. And we have 13 long lead time items that we have received very strong support from a vendor to get built. So our ability to deploy those 13 rapidly is certainly in place. We just need the financial closing to accelerate beyond the current pace we have right now.”
— Eric McAfee, Chairman and CEO
Assessment. Equipment availability takes time out of construction. Funding determines whether another installation contributes earnings or absorbs more capital from the current network.
Dairy volumes through a full seasonal cycle
The question asked how to use the recent run rate with 14 digesters. Management explained that the recent operating period included summer. The operations team also reported yields above its original assumptions, which helps explain the high summer run rate.
Q: “It looks like the last 2 quarters you were running about 600 thousand MMBtus on an annualized basis. […] With the addition, you know, again, up to the 14, though, how should we be thinking about the out year and term of MMBtu generation?”
— David Storms, Stonegate
A: “During the winter time, there is less solar energy. We do not have quite as much production.”
— Eric McAfee, Chairman and CEO
Assessment. We model a full-year production figure around the company’s October estimate and use a lower average quarterly volume than summer Q3 sales. Faster growth requires evidence of sustained yields across seasons.
Cost to turn the tax credit into cash
Asked whether discounts had tightened with the new model, management described a stable market and a planning haircut that includes fees and buyer economics.
Q: “With the update to the model, are you starting to see those discounts decrease or just maybe any comments you have on the tax credit market?”
— David Storms, Stonegate
A: “We usually model about a 15% discount all-in, including insurance and lawyers and brokers and tax lawyers and more tax lawyers. That is probably more of a discount than we are actually getting, but that is the way we usually model it.”
— Eric McAfee, Chairman and CEO
Assessment. At a gross $62 per MMBtu, that haircut leaves about $53 before the proceeds are allocated. A bigger pool of credits improves cash dollars even at an unchanged transfer discount. We anchor the revenue forecast to the current-quarter credit income and use the haircut to gauge the cash economics of additional volumes.
What They're NOT Saying
- Terms for the permanent Keyes financing. There is still no size, borrowing cost or closing date. A closing at a meaningfully lower rate would create room for capex and reduce the amount raised through the ATM.
- What the lender will allow Aemetis to retain. An allocation by use for the July and September sales would show whether the next transfer can pay for operating needs, reduce senior balances and leave enough for construction.
- When the improved ethanol rate becomes recognizable. A documentation pathway exists. Management has yet to quantify eligible Keyes feedstock, confirm a look-back or identify a funded route to the CO₂ reuse benefit.
- What private India customers contribute. Without channel-level volume and margin, it remains hard to tell whether commercial deliveries can fill the trough between tenders. The company also gave no binding IPO timetable or Riverbank SAF financing milestone.
Market Reaction
- Pre-print setup. AMTX closed November 4 at $1.25, down 10.1% year to date, 39.3% over twelve months and 30.2% over thirty days. The pre-print 52-week closing range was $1.15 to $3.66.
- November 5 reaction session. The shares opened at $1.73, traded between $1.56 and $1.96 and closed at $1.73, up 38.4%. Volume of 16.6M was 22.3× the 30-day average. The S&P 500 fell 4.4% that day.
The open followed the earnings release and preceded the call by several hours. That timing points to the surprise in reported profit and sales as the first catalyst. The stock held the opening gain into the close, even as the broader market sold off. The call gave investors a better basis for valuing recurring dairy production and a later date for material savings at Keyes.
Street Perspective
How much of the beat can carry forward?
Bull view. The recurring dairy rate gives each new MMBtu a higher value, and sales still exceeded the top of the published estimate range excluding the catch-up.
Bear view. The catch-up provided all of the quarter’s net profit, and a substantial part of recurring EBITDA still relies on a credit with a statutory end date.
Our take. A repeatable ~$14M EBITDA quarter would materially improve the prospects for a refinance. We would pay for further improvement once the higher rates and cash receipts persist through lower seasonal production.
Can the capital structure catch up?
Bull view. The preferred extension and two large cash receipts give Aemetis time and a stronger earnings record to present to lenders.
Bear view. The lender retains its demand rights, recurring interest cost exceeds cash paid by a wide margin, and the company still needs funding to finish its projects.
Our take. The proposed cash sweep would repay preferred-related debt before surplus dairy cash reaches the parent. The terms of a senior refinance and the amount of capex that can be funded without more expensive debt will determine how much of that upside common holders receive.
Model Implications and Valuation
| Driver | Prior underwriting | Updated underwriting |
|---|---|---|
| Quarterly 45Z revenue | $8M–$9M at prior rates | About $13M–$14M on current output before MVR and additional ethanol rate changes |
| Keyes MVR | 2027 benefit, following end-2026 commissioning | $12.5M in FY2027 EBITDA, comprising $4M gas and $8.5M incremental credits |
| India | Roughly $17M tender across Q3–Q4, IPO subject to markets | Existing domestic sales, with export scale and standalone IPO proceeds excluded |
| Interest and accretion | About $15M per quarter and rising | About $65M in FY2027, with the lower preferred rate and continued senior accommodation |
| ATM issuance | 8%–10% annual dilution | 76M common shares in the base valuation versus 73.1M outstanding on October 31 |
Estimate bridge. Nine-month revenue of $205.5M and adjusted EBITDA of $33.2M plus our Q4 estimates imply roughly $283M and $47M for FY2026. For FY2027, annualized Q3 revenue excluding the catch-up is $308.6M. We subtract about $3M for dairy seasonality at 600,000 MMBtu, and add $8.5M of MVR credit revenue and about $3.5M of incremental corn oil sales, reaching about $318M. On EBITDA, the same starting basis yields $55.2M. A $2.4M seasonal adjustment, $12.5M of MVR benefits and $2.7M from corn oil take that to about $68M. The seasonal adjustment values roughly 33,000 fewer MMBtu versus the Q3 annualized sales rate at about $73 per MMBtu of incremental contribution. The 600,000 MMBtu production outlook serves as an approximate sales assumption. Even at $68M of EBITDA, roughly $65M of financing expense and $16M of depreciation, amortization and stock compensation imply a net loss in the low teens before small tax and other items.
Financing bridge. At $1.73 and 73.1M shares, current equity value is about $126.5M. Adding $435.4M of debt and the $123.6M preferred carrying value and subtracting $3.4M cash gives about $682M of enterprise value. For the 12-month base case, $68M EBITDA less $65M of economic financing cost and $15M net cash capex leaves a roughly $12M gap before working capital. Roughly $5M in ATM proceeds covers part of it, with the rest increasing net debt and preferred claims to about $563M. The $15M is a constrained-spending case. The two digesters are operating and Keyes has acquired its major equipment, so we assume remaining installation and maintenance take priority and other expansion waits for funding. Any new consolidated project debt still counts toward claims. If net capex reaches $25M and the extra spending is debt-funded, base value falls to about $1.41. We assume working capital and credit receipts broadly track earnings over the year.
12-month valuation. We value FY2027 adjusted EBITDA at an illustrative 10×, close to the roughly 10× implied by the reaction close and our base estimate. We use the same multiple in all scenarios to isolate operating and financing risk. The prior recap framed the EV hurdle against a range of delivered and prospective run rates. The updated method values a single forward period and subtracts the senior claims before assigning value to common. That multiple requires investors to credit the assets with value beyond the scheduled 45Z expiry at the end of 2029. Over $50M of annualized credit revenue at the current-period run rate is at risk at expiry before any MVR gains. A 9× multiple would put base value at roughly $0.64 per share. There is no separate IPO or SAF value and we assume no dividends.
| 12-month scenario | FY2027 adj. EBITDA | EV at 10× | Net debt and preferred | Shares | Value / share | Total return |
|---|---|---|---|---|---|---|
| Bear | $60M | $600M | $575M | 80M | $0.31 | −82% |
| Base | $68M | $680M | $563M | 76M | $1.54 | −11% |
| Bull | $82M | $820M | $530M | 76M | $3.82 | +121% |
The bear case loses $8M of EBITDA if credit certification or Keyes commissioning slips, adds $12M of claims and assumes extra issuance. A lender enforcement outcome can take the common recovery lower. The bull case adds $14M from earlier MVR benefits and additional dairy/LCFS margin, and needs about $26M of net claim reduction from today’s level. For that to work, retained credit-sale cash and refinancing savings need to reach principal, with new construction separately funded or deferred. A single turn of the multiple changes the base value by roughly $0.89 per share.
With a 20% bear weight as a sensitivity, the bull case needs roughly one chance in four for AMTX to match an illustrative 8% S&P 500 total return. Moving 10 percentage points between the base and bull cases moves expected return by about 13 points. The dairy reset and preferred extension make that upside plausible, but the bull case also requires faster commissioning and actual debt reduction. With no senior financing terms and total debt up $19.6M this quarter, we see little basis for expecting a return above that hurdle. Maintain Hold at conviction 5.
Thesis Scorecard Post-Earnings
| Standing pillar | Quarter assessment | Status | Evidence and consequence |
|---|---|---|---|
| Bull 1 · Catalyst stack printing | Confirmed | ON TRACK | Dairy rate and throughput carry earnings higher. Keyes retrofit timing pushes the bulk of savings into H2 2027. |
| Bull 2 · Policy backdrop | Confirmed | AT RISK → ON TRACK | Dairy GREET reset booked and sold, LCFS realization improves. Incremental corn and CO₂ benefits remain outside base. |
| Bull 3 · India + SAF optionality | Mixed | AT RISK | India volumes rebound. Export economics, IPO timing and Riverbank funding remain open. |
| Bear 1 · Liquidity / leverage | Confirmed | MATERIALIZING | Preferred relief helps, while demand debt rises and Keyes needs another waiver. |
| Bear 2 · Credit-monetization timing | Confirmed | EMERGING | Second sale supports operating cash. Timing, allocation and sustained debt paydown remain open. |
| Bear 3 · Structural dilution | Confirmed | MATERIALIZING | Slower ATM sales at a lower net price per share. Equity remains part of the funding plan. |
Next-quarter signposts. December preferred resolution and terms for any Keyes takeout come first. We also want to see the next recurring credit sale and resulting debt balances, updated covenant status, construction and commissioning dates at Keyes, the third oil separator in operation, winter RNG volumes and new CARB pathways, and India tender deliveries or approved exports with disclosed economics. The share count and price of issuance show how much of any financing gap is falling to common.
Action. Maintain Hold. A closed refinance at a materially lower blended rate or recurring adjusted EBITDA above financing expense paired with positive cash after capex would put an upgrade back in view, subject to price. A lender demand, an unwaived breach or a heavily discounted equity raise would lower our estimate of common recovery.